High Sensitivity Flu A+B Test

Response Biomedical has received FDA clearance to market a new high sensitivity rapid test for detecting Influenza A and B (Flu A+B). Initial results suggest the capability of producing highly sensitive and reliable information with significant performance improvements over established rapid immunoassays.
 
Due to the limited sensitivity of current rapid screening tests, there is a substantial market opportunity for a rapid high sensitivity flu test. Improved rapid screening will enable early detection, containment, and treatment of patients in a hospital or physician office setting. Response Biomedical anticipates its RAMP System will establish a new industry standard in rapid Flu A&B testing worldwide. Read More on Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Influenza A+B Test
 
The test will be marketed and sold exclusively by 3M as the 3M Rapid Detection Influenza A+B test. Visit the US 3M Medical Diagnostics web site at www.howtocatchtheflu.com
 
 

The Flu Virus

 
Influenza (the flu) is a contagious disease that is caused by the influenza virus. It attacks the respiratory tract in humans (nose, throat, and lungs). The Three Types of Influenza Viruses are: Influenza A, B, and C. Influenza types A or B viruses cause epidemics of disease almost every winter.
 

Global Disease

 
During the influenza epidemics every year, an estimated half a million people die worldwide. In 2001, only 250 million vaccine doses were used globally, whereas the people at greatest risk of dying from influenza - those aged over 65 - already number more than 380 million¹.
 
 

---

Read More

 
¹ Influenza - WHO cares?
 
Centers for Disease Control and Prevention - Flu
 
Public Health Agency of Canada - FluWatch
 
FluStar
 
World Health Organization
 
World Health Organization guidelines for Flu A diagnostic testing